• This topic has 1 voice and 0 replies.
Viewing 0 reply threads
  • Author
    Posts
    • #14840
      Forum Moderator
      Keymaster

      Prevail Therapeutics’ plans to soon open a Phase 1/2 trial of PR001, a potential one-time gene therapy for Parkinson’s patients with GBA1 gene mutations. Read more about the trial here.

      What do you think about this news?

Viewing 0 reply threads
  • You must be logged in to reply to this topic.
Copyright © 2017-2019 All rights reserved.

©2019 KLEO Template a premium and multipurpose theme from Seventh Queen

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending
or

Log in with your credentials

or    

Forgot your details?

or

Create Account